1952.HKEarnings•prnewswire•
Everest Medicines to Announce 2025 Interim Results on August 29, 2025
Sentiment:Negative (10)
Summary
SHANGHAI, Aug. 11, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that it will report its...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 11, 2025 by prnewswire